Page last updated: 2024-10-25

deferoxamine and Hibernation, Myocardial

deferoxamine has been researched along with Hibernation, Myocardial in 4 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Research Excerpts

ExcerptRelevanceReference
"Deferoxamine treated control myocytes responded similarly."1.36Hypoxia inducible factor-1 protects against nitrate tolerance and stunning in rabbit cardiac myocytes. ( Tan, T; Weiss, HR, 2010)
"Deferoxamine-treated control myocytes responded similarly."1.35Hypoxia inducible factor-1 improves the actions of positive inotropic agents in stunned cardiac myocytes. ( Luciano, JA; Scholz, PM; Tan, T; Weiss, HR, 2009)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tan, T2
Luciano, JA1
Scholz, PM1
Weiss, HR2
Klawitter, PF1
Murray, HN1
Clanton, TL1
Angelos, MG1
Paraskevaidis, IA1
Iliodromitis, EK1
Vlahakos, D1
Tsiapras, DP1
Nikolaidis, A1
Marathias, A1
Michalis, A1
Kremastinos, DT1

Trials

1 trial available for deferoxamine and Hibernation, Myocardial

ArticleYear
Deferoxamine infusion during coronary artery bypass grafting ameliorates lipid peroxidation and protects the myocardium against reperfusion injury: immediate and long-term significance.
    European heart journal, 2005, Volume: 26, Issue:3

    Topics: Coronary Artery Bypass; Coronary Artery Disease; Deferoxamine; Echocardiography, Transesophageal; Hu

2005

Other Studies

3 other studies available for deferoxamine and Hibernation, Myocardial

ArticleYear
Hypoxia inducible factor-1 improves the actions of positive inotropic agents in stunned cardiac myocytes.
    Clinical and experimental pharmacology & physiology, 2009, Volume: 36, Issue:9

    Topics: Animals; Antifungal Agents; Calcium Signaling; Cardiotonic Agents; Ciclopirox; Colforsin; Deferoxami

2009
Hypoxia inducible factor-1 protects against nitrate tolerance and stunning in rabbit cardiac myocytes.
    Cardiovascular drugs and therapy, 2010, Volume: 24, Issue:2

    Topics: Animals; Calcium-Binding Proteins; Carbazoles; Cell Shape; Cyclic GMP-Dependent Protein Kinases; Def

2010
Reactive oxygen species generated during myocardial ischemia enable energetic recovery during reperfusion.
    American journal of physiology. Heart and circulatory physiology, 2002, Volume: 283, Issue:4

    Topics: 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt; Acetylcysteine; Adenosine Triphosphate; Anim

2002